Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacillus Calmette‐Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I‐deficient tumor cells
Rafael Carretero, Teresa Cabrera, Hernani Gil, et al.
International Journal of Cancer (2010) Vol. 129, Iss. 4, pp. 839-846
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Therapeutic cancer vaccines
Mansi Saxena, Sjoerd H. van der Burg, Cornelis J.M. Melief, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 360-378
Closed Access | Times Cited: 1082
Therapeutic cancer vaccines
Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3401-3412
Open Access | Times Cited: 1038
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy, Jeff D. Colbert, Kenneth L. Rock
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 683
Rejection versus escape: the tumor MHC dilemma
Federico Garrido, Francisco Ruiz‐Cabello, Natalia Aptsiauri
Cancer Immunology Immunotherapy (2016) Vol. 66, Iss. 2, pp. 259-271
Closed Access | Times Cited: 137
Intratumour Heterogeneity in Urologic Cancers: From Molecular Evidence to Clinical Implications
Marco Gerlinger, James W.F. Catto, Torben F. Ørntoft, et al.
European Urology (2014) Vol. 67, Iss. 4, pp. 729-737
Closed Access | Times Cited: 113
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
Mónica Bernal, Francisco Ruiz‐Cabello, Ángel Concha, et al.
Cancer Immunology Immunotherapy (2012) Vol. 61, Iss. 9, pp. 1359-1371
Closed Access | Times Cited: 108
The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses
Natalia Aptsiauri, Francisco Ruiz‐Cabello, Federico Garrido
Current Opinion in Immunology (2018) Vol. 51, pp. 123-132
Closed Access | Times Cited: 101
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy
Per Anderson, Natalia Aptsiauri, Francisco Ruiz‐Cabello, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 556-565
Open Access | Times Cited: 77
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon‐mediated rejection genes
Rafael Carretero, Ena Wang, Ana Isabel Enríquez Rodríguez, et al.
International Journal of Cancer (2011) Vol. 131, Iss. 2, pp. 387-395
Open Access | Times Cited: 86
The absence of HLA class I expression in non‐small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration
Francisco Perea, Mónica Bernal, Abel Sánchez‐Palencia, et al.
International Journal of Cancer (2016) Vol. 140, Iss. 4, pp. 888-899
Open Access | Times Cited: 84
MHC/HLA Class I Loss in Cancer Cells
Federico Garrido
Advances in experimental medicine and biology (2019), pp. 15-78
Closed Access | Times Cited: 65
Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines
Mariam Oladejo, Wyatt Paulishak, Laurence M. Wood
Seminars in Cancer Biology (2022) Vol. 88, pp. 81-95
Open Access | Times Cited: 35
The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes
Natalia Aptsiauri, Federico Garrido
Clinical Cancer Research (2022) Vol. 28, Iss. 23, pp. 5021-5029
Open Access | Times Cited: 34
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
Mathieu Rouanne, Julien Adam, C. Radulescu, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 30
Current status and future of cancer vaccines: A bibliographic study
Rui Yu, Fangmin Zhao, Zeting Xu, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24404-e24404
Open Access | Times Cited: 7
HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15
María Antonia Garrido, Teresa Rodríguez, S. P. Zinchenko, et al.
Immunogenetics (2018) Vol. 70, Iss. 10, pp. 647-659
Closed Access | Times Cited: 47
Targeting HLA class I expression to increase tumor immunogenicity
Ana Belén Campo, Javier Carretero, Natalia Aptsiauri, et al.
Tissue Antigens (2012) Vol. 79, Iss. 3, pp. 147-154
Open Access | Times Cited: 52
Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance
Francisco Javier Carretero, Ana Belén Campo, José Francisco Flores-Martín, et al.
Cancer Immunology Immunotherapy (2015) Vol. 65, Iss. 1, pp. 47-59
Closed Access | Times Cited: 47
Treatment of non-muscle invasive bladder cancer with Bacillus Calmette–Guerin (BCG): Biological markers and simulation studies
Alex S. Kiselyov, Svetlana Bunimovich‐Mendrazitsky, Vladimir Startsev
BBA Clinical (2015) Vol. 4, pp. 27-34
Open Access | Times Cited: 45
Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype
Federico Garrido, Irene Gallego Romero, Natalia Aptsiauri, et al.
International Journal of Cancer (2014) Vol. 138, Iss. 2, pp. 271-280
Open Access | Times Cited: 42
HLA Class-I Expression and Cancer Immunotherapy
Federico Garrido
Advances in experimental medicine and biology (2019), pp. 79-90
Closed Access | Times Cited: 42
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition
Michael Campoli, Soldano Ferrone
Seminars in Immunopathology (2011) Vol. 33, Iss. 4, pp. 321-334
Open Access | Times Cited: 42
Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function
Ricardo D. Lardone, Alfred A. Chan, Agnes F. Lee, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 35
Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets
Chaozhi Tang, Jiakang Ma, Xiuli Liu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 30
Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires
Cláudia C. Oliveira, Bianca Querido, Marjolein Sluijter, et al.
European Journal of Immunology (2011) Vol. 41, Iss. 11, pp. 3114-3124
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top